U.S. Life Sciences Stock News

TPG RE Finance Trust (TRTX) closed out FY 2025 with Q4 revenue of US$23.8 million and basic EPS of roughly US$0.00, capping a year where quarterly revenue moved between US$23.8 million and US$40.4 million while EPS ranged from about US$0.00 to US$0.23. Across the last six reported quarters, revenue has run between US$23.8 million and US$40.4 million with EPS between roughly US$0.00 and US$0.23, giving investors a clear view of how income streams have shifted through recent reporting periods...

Amdocs (DOX) has opened Q1 2026 with revenue of US$1.2 billion and basic EPS of US$1.46, setting the tone for investors focused on how profit is tracking against prior quarters. The company has seen quarterly revenue hold around the US$1.1 billion mark over the past year, from US$1.11 billion in Q1 2025 to US$1.16 billion in Q1 2026. Over the same period, basic EPS moved from US$1.34 to US$1.46, and trailing twelve month EPS sits at US$5.19. With net profit margins having improved over the...

Toll Brothers (TOL) opened its 2026 fiscal year with Q1 revenue of US$2.1b and basic EPS of US$2.20, setting the tone for how its upscale housing demand is feeding through to the bottom line. The company has seen quarterly revenue move from US$1,859.1m and EPS of US$1.76 in Q1 2025 to US$2,145.6m and EPS of US$2.20 in Q1 2026. Trailing 12 month EPS sits at US$14.12 on revenue of US$11.3b, giving investors a clear view of scale. With a trailing net margin of 12.3% versus 14.0% last year, the...

Rush Enterprises (RUSHA) closed out FY 2025 with Q4 revenue of US$1.8 billion and basic EPS of US$0.83, alongside net income of US$64.3 million, setting the tone for how the year’s trading performance lands for shareholders. Over the last six quarters, the company has seen quarterly revenue move between US$1.8 billion and US$2.0 billion, while basic EPS ranged from US$0.76 to just under US$1.00. This gives a clear view of how top line and per share earnings have tracked together. With...

Innospec (IOSP) has wrapped up FY 2025 with Q4 revenue of US$455.6 million and basic EPS of US$1.91, alongside trailing twelve month revenue of US$1.8 billion and EPS of US$4.69 that sit against a year of sharply higher earnings growth and a net margin of 6.6% versus 1.9% a year earlier. Over recent periods, revenue has ranged from US$439.7 million to US$466.8 million per quarter, while quarterly EPS has moved between a loss of US$2.82 and a gain of US$1.91. This sets the stage for investors...

Elite Pharmaceuticals (ELTP) just posted its Q3 2026 numbers, with revenue of US$31.6 million, basic EPS of US$0.017, and net income of US$18.6 million, while on a trailing twelve month basis revenue sits at US$140.1 million and EPS at US$0.040. Over the past few quarters, the company has seen revenue move between US$14.4 million and US$40.2 million per quarter, with basic EPS ranging from a loss of US$0.010 to a profit of US$0.018, and trailing twelve month EPS shifting from a loss of...

How Cohu’s FY 2025 Numbers Set the Stage for the Next Chapter Cohu (COHU) closed FY 2025 with Q4 revenue of US$122.2 million and a basic EPS loss of US$0.48, alongside trailing twelve month revenue of US$453.0 million and an EPS loss of US$1.59. Over recent quarters, the company has seen revenue move from US$94.1 million in Q4 2024 to US$96.8 million in Q1 2025, US$107.7 million in Q2 2025, US$126.2 million in Q3 2025, and US$122.2 million in Q4 2025, while quarterly EPS losses ranged between...

Global Payments (GPN) has put fresh numbers on the table, with Q3 FY 2025 revenue of US$2,007.6 million and basic EPS of US$1.87 setting the tone, while trailing twelve month EPS sits at US$6.67 on revenue of US$10.1 billion. The company has seen revenue move from US$1,997.7 million in Q3 FY 2024 to US$2,007.6 million in Q3 FY 2025, alongside a shift in basic EPS from US$1.12 to US$1.87 over the same period. Investors are likely to focus on how these results feed into a story of earnings...

LCI Industries (LCII) has put solid numbers on the board for FY 2025 so far, with third quarter revenue of US$1.0b and basic EPS of US$2.56, alongside trailing twelve month revenue of US$4.0b and EPS of US$7.13 that reflect the sharp 36.8% earnings growth and a 4.5% net margin reported over the last year. The company has seen revenue move from US$803.1m in Q4 2024 to above US$1.0b in each of the first three quarters of 2025. Quarterly EPS shifted from US$0.37 in Q4 2024 to US$1.94, US$2.29...

Eversource Energy (ES) closed out FY 2025 with Q4 revenue of US$3.4 billion and basic EPS of US$1.12, alongside trailing twelve month revenue of US$13.5 billion and EPS of US$4.56 that coincided with earnings growth of 108.5% over the past year. The company has seen trailing twelve month revenue move from US$11.9 billion to US$13.5 billion, while trailing EPS shifted from US$2.27 to US$4.56 as net profit margin moved from 6.8% to 12.5%, setting up a story where healthier profitability is...

Sonic Automotive (SAH) has put up a mixed scorecard for FY 2025 so far, with Q3 revenue of US$4.0b, basic EPS of US$1.38 and net income of US$46.8m, alongside reported trailing 12 month revenue of US$15.2b and basic EPS of US$3.82. The company has seen quarterly revenue move from US$3.5b in Q3 2024 to US$4.0b in Q3 2025, while basic EPS has shifted from US$2.18 to US$1.38 over the same periods. This sets up a story where decent top line momentum meets thinner margins and leaves investors...

Insulet (PODD) just put up third quarter FY 2025 numbers with revenue of US$706.3 million and basic EPS of US$1.24, alongside net income of US$87.6 million, setting the tone for how the rest of the year is shaping up. The company has seen revenue move from US$488.5 million in Q2 2024 to US$649.1 million in Q2 2025 and US$706.3 million in Q3 2025, while basic EPS shifted from US$2.69 to US$0.32 and then US$1.24 over the same quarters. This gives investors a clear view of how the top line and...

Caesars Entertainment (CZR) closed out FY 2025 with fourth quarter revenue of US$2.9 billion, a basic EPS loss of US$1.23 and a net income loss of US$250 million, compared with revenue of US$2.8 billion, basic EPS of US$0.05 and net income of US$11 million in the same quarter a year earlier. Over the past year, the company has seen quarterly revenue range from US$2.8 billion to US$2.9 billion, while basic EPS moved from a US$0.27 loss in Q3 2025 to a US$1.23 loss in Q4 2025. Trailing twelve...

Element Solutions (ESI) just wrapped up FY 2025 with fourth quarter revenue of US$676.2 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$2.6 billion and EPS of US$0.79 that sit against a net profit margin of 7.5%. Over recent quarters the company has seen revenue move from US$593.7 million and EPS of US$0.40 in Q1 2025 to US$676.2 million and EPS of US$0.03 in Q4 2025, while the last 12 months also include a US$59.0 million one off gain and a P/E of 42.9x that...

JBG SMITH Properties (JBGS) has capped FY 2025 with fourth quarter revenue of US$127.7 million, a basic EPS loss of US$0.75, and funds from operations of US$13.9 million in losses, setting a cautious tone around earnings quality. The company has seen quarterly revenue move from US$130.4 million in Q4 2024 to US$127.7 million in Q4 2025. Trailing twelve month revenue sits at US$498.6 million and EPS over the same period is a loss of US$2.06, which keeps the focus squarely on how efficiently...

USANA Health Sciences (USNA) closed FY 2025 with Q4 revenue of US$226.2 million and a basic EPS loss of US$0.10, as net income excluding extra items came in at a loss of US$1.8 million. Over the last six reported quarters, revenue has moved between US$200.2 million and US$249.5 million, while quarterly basic EPS has ranged from a profit of US$0.56 to a loss of US$0.36, and trailing twelve month EPS stood at US$0.58 on revenue of US$925.3 million in Q4 2025. For investors, the key story this...

MKS (MKSI) has wrapped up FY 2025 with Q4 revenue of US$1.0b and basic EPS of US$1.60, alongside trailing twelve month revenue of US$3.9b and EPS of US$4.38 that sit against a 55.3% earnings lift over the past year. The company has seen quarterly revenue move from US$934m in Q4 2024 to US$1.0b in Q4 2025, while basic EPS shifted from US$1.35 to US$1.60 over the same period. Analysts are forecasting 27.9% annual earnings growth and higher net profit margins, keeping investor attention firmly...

Mach Natural Resources (NYSE:MNR) is working through integration challenges tied to newly acquired oil assets in the Central Basin Platform. At the same time, the company has announced an increase in its quarterly cash distribution to unitholders. The combination of operational complexity and higher cash returns has drawn fresh attention from investors and analysts. Mach Natural Resources comes into this news with a recent unit price of $13.31 and a mixed return profile. The units are up...

NewAmsterdam Pharma has begun late stage RUBENS Phase 3 trials of obicetrapib in patients with Type 2 diabetes and metabolic syndrome. The company also plans to launch a new trial of obicetrapib in early Alzheimer's disease. These programs expand obicetrapib's potential use into major cardiometabolic and neurological conditions. For investors watching NasdaqGM:NAMS, these trial moves come as the stock trades at $35.24 and has returned 75.8% over the past year and 237.2% over the past five...

If you are trying to figure out whether Bitgo Holdings at around US$10.87 is a bargain or a value trap, starting with a clear view of what the current price reflects can help you frame the opportunity and the risks. The stock has seen a 1.4% decline over the last 7 days and a 41.2% decline year to date, which can change how the market views its growth potential and risk profile. Recent coverage around Bitgo Holdings has focused on its role in digital asset custody and broader crypto market...

Why Canaan’s latest numbers matter for shareholders Canaan (NasdaqGM:CAN) just released fourth quarter and full year 2025 results, fresh earnings guidance for the first quarter of 2026, and January Bitcoin production data, giving investors several new reference points to assess the stock. For the fourth quarter ended December 31, 2025, Canaan reported revenue of US$196.27 million, compared with US$88.77 million a year earlier. The company recorded a net loss of US$85.04 million for the...

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench. These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance. Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...

The Brink’s Company has appointed Adrian Button as executive vice president and president of Brink’s North America, effective February 16, 2026, adding him to the executive leadership team reporting to CEO Mark Eubanks. With more than 30 years of global operational leadership at GE, NCR, and Carrier overseeing multibillion-dollar businesses and large-scale supply chains, Button’s background directly aligns with Brink’s focus on operational efficiency and service quality in North...

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing 515 points and the S&P 500 nearing a record high. Amid this positive momentum, investors may find opportunities in stocks that appear to be trading below their estimated fair value, potentially offering attractive entry points in a market characterized by robust gains and evolving economic conditions.